Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD

NCT04500847 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease, Early Onset
Mild Cognitive Impairment
Moderate Dementia

Interventions

DRUG: Emtriva Capsule
DRUG: Placebo

Sponsor

Butler Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]